Michael F. DeMane - 26 May 2022 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael DeMane
Issuer symbol
N/A
Transactions as of
26 May 2022
Net transactions value
$0
Form type
4
Filing time
27 May 2022, 20:57:08 UTC
Previous filing
04 Apr 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +4,155 +10% $0.000000 44,302 26 May 2022 Direct F1, F2
holding NVRO Common Stock 148,775 26 May 2022 See footnote F3
holding NVRO Common Stock 71,986 26 May 2022 See footnote F4
holding NVRO Common Stock 11,600 26 May 2022 See footnote F5
holding NVRO Common Stock 47,980 26 May 2022 See footnote F6
holding NVRO Common Stock 49,911 26 May 2022 See footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 26, 2022 or (ii) the next Annual Meeting following May 26, 2022, subject to the Reporting Person's continued service to the issuer.
F2 Includes 4,155 restricted stock units.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F4 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
F5 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F6 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 04/23/2021.
F7 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.